The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Merck; Novartis; Onyx; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Merck; Novartis; Onyx; Takeda
Research Funding - Onyx; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen; Merck; Novartis; Onyx; Takeda
Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, anti-CD38 mAb) in relapsed/refractory multiple myeloma (RRMM).
 
Joshua Ryan Richter
Honoraria - Amgen; Celgene; Janssen; Novartis; Takeda
Consulting or Advisory Role - Amgen; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen; Novartis; Takeda
 
Thomas G. Martin
Research Funding - Sanofi (Inst)
 
Ravi Vij
No Relationships to Disclose
 
Craig Cole
Travel, Accommodations, Expenses - Amgen
 
Djordje Atanackovic
Speakers' Bureau - Celgene; Onyx; Takeda
 
Jeffrey A. Zonder
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Celgene; Prothena
Research Funding - Celgene
 
Jonathan L. Kaufman
Honoraria - Janssen
Consulting or Advisory Role - Celgene; Incyte; Millennium; Novartis; Onyx; Spectrum Pharmaceuticals
Research Funding - Celgene (Inst); Merck (Inst); Novartis (Inst)
 
Joseph Mikhael
Research Funding - Abbvie (Inst); Celgene (Inst); Onyx (Inst); Sanofi (Inst)
 
William Bensinger
Honoraria - Amgen; Celgene
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Sanofi
Speakers' Bureau - Amgen; Celgene
Research Funding - Acetylon Pharmaceuticals; Amgen; Bristol-Myers Squibb; Celgene; Sanofi; Takeda
 
Meletios A. Dimopoulos
Consulting or Advisory Role - Celgene; Janssen; Novartis; Onyx
 
Todd M. Zimmerman
Consulting or Advisory Role - Celgene; Onyx; Takeda
Speakers' Bureau - Celgene; Onyx; Takeda
 
Nikoletta Lendvai
No Relationships to Disclose
 
Parameswaran Hari
Stock and Other Ownership Interests - Pharmacyclics
Honoraria - Amgen; Celgene; Millennium; Novartis; Sanofi; Spectrum Pharmaceuticals
Consulting or Advisory Role - Celgene; Millennium; Onyx; Sanofi
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)
 
Enrique M. Ocio
Honoraria - Amgen/Onyx; Bristol-Myers Squibb; Celgene; Janssen; Mundipharma; Novartis; Takeda
Consulting or Advisory Role - Amgen/Onyx; Array BioPharma; Celgene; Mundipharma; Novartis
Research Funding - Amgen/Onyx; Array BioPharma; Celgene; Mundipharma
Travel, Accommodations, Expenses - Celgene; Janssen
 
Cristina Gasparetto
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Millennium
Consulting or Advisory Role - Celgene; Millennium; Onyx
Speakers' Bureau - Celgene; Millennium
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene; Millennium
 
Shaji Kumar
Consulting or Advisory Role - Kesios Therapuetics; Noxxon Pharma; Skyline Diagnostics
Research Funding - Abbvie; Celgene; Janssen; Millennium; Novartis; Onyx; Sanofi
 
Corina Oprea
Employment - Sanofi
 
Eric Charpentier
Employment - Sanofi
 
Stephen Anthony Strickland
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Baxalta; Boehringer Ingelheim; CTI; Daiichi Sankyo; Sunesis Pharmaceuticals
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Celator (Inst); Cyclacel (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Sanofi (Inst); Sunesis Pharmaceuticals (Inst)
 
Jesus San Miguel
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Millennium; MSD; Novartis; Onyx